Skip to main content
OpenTrials

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

2,296 public trials 506 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Completed

A Clinical Study of Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab to Patients With Advanced Platinum-sensitive Ovarian Cancer

NCT03695380

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • University of Arizona Cancer Center, North Tucson, Arizona, United States
  • Moores Cancer Center at UC San Diego Health La Jolla, California, United States
  • Mayo Clinic-Jacksonville Jacksonville, Florida, United States
  • Florida Hospital Cancer Institute; Clinical Research Department Orlando, Florida, United States
View all 20 locations
View Trial Details
Completed

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

NCT03602079

Conditions
Adenocarcinoma, Adnexal Diseases, Bile Duct Cancer, +129 more
Locations
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
  • Beth Israel Deaconess Medical Center Cancer Center Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Clinical Research Alliance, Inc. Lake Success, New York, United States
View Trial Details
Completed

EP0057 in Combination With Olaparib in Advanced Ovarian Cancer

NCT04669002

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • University of California Irvine Irvine, California, United States
  • Florida Cancer Specialists and Research Institute Lady Lake, Florida, United States
  • Augusta University Augusta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 21 locations
View Trial Details
Completed

Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors

NCT02988817

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +46 more
Locations
  • Mayo Clinic - Phoenix Phoenix, Arizona, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • Yale University, Smilow Cancer Center at Yale New Haven Hospital New Haven, Connecticut, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
View all 41 locations
View Trial Details
Completed

Phase II Study of AZD2281 in Patients With Known BRCA Mutation Status or Recurrent High Grade Ovarian Cancer or Patients With Known BRCA Mutation Status/ Triple Neg Breast Cancer

NCT00679783

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +19 more
Locations
  • Research Site Edmonton, Alberta, Canada
  • Research Site Vancouver, British Columbia, Canada
  • Research Site Halifax, Nova Scotia, Canada
  • Research Site Hamilton, Ontario, Canada
View Trial Details
Completed

A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200)

NCT02580058

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Arizona Oncology Associates, PC - HAL Chandler, Arizona, United States
  • Arizona Oncology Associates, PC - HAL Phoenix, Arizona, United States
  • Arizona Oncology Associates, PC - HAL Phoenix, Arizona, United States
  • Arizona Oncology Associates, PC - HAL Scottsdale, Arizona, United States
View all 295 locations
View Trial Details

Related conditions